Follows adults with hip joint disease who receive the SMS femoral stem implant
Tracks how the SMS hip implant performs in adults with hip joint disease.
Plain-language title generated from the registry record
Registry title: The Medacta International SMS Post-Marketing Surveillance Study
Key facts
- Where
- Milan, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT02748408, who can take part
Where in Italy
- Istituto Ortopedico GalezziMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medacta International SA
- Trial code
- NCT02748408
- Record updated
- 13 October 2026
- Original description
This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.Read full original descriptionShow less
The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study
This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.
Inclusion: Individuals with a severely painful and/or disabling hip joint with osteoarthritis, traumatic arthritis or developmental dysplasia of the hip or avascular necrosis of the femoral head; In order to take part in this study, all study participants must be between the ages of 18 and 75 years of age, at the time of surgery; Scheduled for a primary total hip replacement.
Exclusion: Osteomalacia where uncemented implant fixation is contraindicated; Active infection; Mental illness where the known condition is likely to compromise the patient's ability to consent, affect the patient's assessment of their progress or complete the 10 year cycle of follow-up appointments and reviews; Metabolic disorders which may impair bone formation where uncemented implant fixation is contraindicated; Muscular atrophy or neuromuscular disease; Allergy to implant material; Pregnancy; Grossly distorted anatomy (surgeon's discretion); Active rheumatoid arthritis; Osteoporosis; Any patient who cannot or will not provide informed consent for participation in the study; Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems.